122 related articles for article (PubMed ID: 9118164)
1. Nisoldipine CC: clinical experience in ischaemic heart disease.
Melcher A; Dens J; Curry P; Hagel H
Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
[TBL] [Abstract][Full Text] [Related]
2. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
3. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Fodor JG
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
[TBL] [Abstract][Full Text] [Related]
4. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
Pepine CJ; Cooper-DeHoff RM; Weiss RJ; Koren M; Bittar N; Thadani U; Minkwitz MC; Michelson EL; Hutchinson HG;
Am J Cardiol; 2003 Feb; 91(3):274-9. PubMed ID: 12565082
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
8. Nisoldipine coat-core and heart rate response during treatment of hypertension.
Zannad F
Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris.
Melcher A; Abelin J; Luurila O
Clin Drug Investig; 1998; 15(5):389-96. PubMed ID: 18370494
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
11. Nisoldipine CC: clinical experience in hypertension.
Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
[TBL] [Abstract][Full Text] [Related]
12. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
Brügmann U; Blasini R; Rudolph W
Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
[TBL] [Abstract][Full Text] [Related]
14. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.
Lewis BS
Am J Cardiol; 1995 Apr; 75(13):46E-53E. PubMed ID: 7726125
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
Deanfield JE
Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of nisoldipine on dipyridamole-induced myocardial ischemia: correlation with exercise electrocardiography.
Lattanzi F; Paperini L; Orsini E; Paci AM; Levantesi D; Topi A; Reisenhofer B; Lucarini AR; Squarcini G
Coron Artery Dis; 1998; 9(4):207-15. PubMed ID: 9649927
[TBL] [Abstract][Full Text] [Related]
18. [Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem].
Kilz U; Knaup G
Fortschr Med; 1991 May; 109(14):309-12. PubMed ID: 2071085
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
de Caprio L; Sestito M; Pandolfi E; Santamaria F; di Palma A; Lombardi L; Voza A; De Rosa ML; Cicatiello AM; Rengo F
G Ital Cardiol; 1994 Feb; 24(2):115-22. PubMed ID: 8013763
[TBL] [Abstract][Full Text] [Related]
20. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
Martsevich SIu; Sementsov DP; Kutishenko NP; Alimova EV
Ter Arkh; 2001; 73(9):42-6. PubMed ID: 11642080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]